Wird geladen...
Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab
The increased propensity of BRCA1 mutation carriers to develop aggressive breast tumors with stem-like properties begins to be understood in terms of osteoprotegerin (OPG)-unrestricted cross-talk between RANKL-overproducing progesterone-sensor cells and cancer-initiating RANK(+) responder cells that...
Gespeichert in:
| Veröffentlicht in: | Cell Cycle |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499830/ https://ncbi.nlm.nih.gov/pubmed/28387573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2017.1310353 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|